Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Follow-up Study on Recipients of Treatment at the Jerusalem Center for the Treatment of Psychotrauma

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Dr. Ruth Pat-Horenzcyk, Herzog Hospital
ClinicalTrials.gov Identifier:
NCT00463138
First received: April 19, 2007
Last updated: September 3, 2013
Last verified: September 2013

April 19, 2007
September 3, 2013
April 2007
March 2008   (final data collection date for primary outcome measure)
depressive symptoms, anxiety, PDS, which measures subjective response to trauma, symptoms, and and level of functioning. [ Time Frame: April 2007- March 2008 ] [ Designated as safety issue: Yes ]
Not Provided
Complete list of historical versions of study NCT00463138 on ClinicalTrials.gov Archive Site
level of family, friend, and other support, Self-Efficacy Scale [ Time Frame: Aprol 2007- March2008 ] [ Designated as safety issue: Yes ]
Not Provided
Traumatic Events Screening Inventory (TESI) [ Time Frame: April 2008- March 2008 ] [ Designated as safety issue: Yes ]
Not Provided
 
Follow-up Study on Recipients of Treatment at the Jerusalem Center for the Treatment of Psychotrauma
Follow-up Study on Recipients of Treatment at the Jerusalem Center for the Treatment of Psychotrauma

Researchers examined perceived satisfaction and perceived increase or decrease in symptoms among recipients of treatment at the Jerusalem Center for the Treatment of Psychotrauma, using self report methods. Researchers hypothesized that a significant number of recipients would report a decrease in their symptoms and general satisfaction with the treatment they received.

Researchers conducted a follow-up study of clients of Meytiv, the clinical branch of the Jerusalem Center for the Treatment of Psychotrauma. Researchers plan to use the results of the study to better understand the demographics of those who come to the Center, and to improve the services offered to our clients. Before beginning treatment, every Meytiv client filled out a questionnaire in which information is requested regarding demographics, trauma history, symptoms, and various levels of functioning. Researchers administered a similar self-report questionnaire to all clients upon completion of treatment. The follow-up questionnaire contained the following several indices: the Traumatic Events Screening Inventory (TESI), which requests a client's trauma history; the Multidimensional Scale of Perceived Social Support, which measures level of family, friend, and other support; the Brief Symptom Inventory, which measures level of various psychiatric symptoms, including somatic complaints, depressive symptoms, anxiety, and paranoid or hostile thoughts; the Self-Efficacy Scale, which measures level of self-reliance and confidence in one's ability to cope with stressors; and PDS, which measures subjective response to trauma, symptoms, and and level of functioning. This questionnaire, which mirrors one completed by all Meytiv's clients before treatment, was administered to those clients who completed treatment within a year of the study. Clients completed the follow-up questionnaire on condition that if they were in need of further treatment, Meytiv would refer them to the appropriate provider. Responses will be coded and analyzed to check significance among potentially related variables, including demographic variables. Most importantly, results of the follow-up questionnaire will be compared to its parallel from the beginning of treatment in order to examine what effects our treatment has on one's symptoms, and whether our clients have been satisfied

Observational
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Probability Sample

All clients who were exposed to a traumatic event within the last 2 years and completed treatment at the Trauma Center within the last year

Healthy
Behavioral: Crisis intervention
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
100
March 2008
March 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • All clients who were exposed to a traumatic event within the last 2 years and completed treatment at the Trauma Center within the last year

Exclusion Criteria:

  • Clients under the age of 12
Both
12 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00463138
Brom3CTIL
Yes
Dr. Ruth Pat-Horenzcyk, Herzog Hospital
Herzog Hospital
Not Provided
Principal Investigator: Danny Brom, Ph.D Israel Center for the Treatment of Psychotrauma
Herzog Hospital
September 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP